Recently, BDP1 alterations in human cancers have been identified,34, 35, 36 including BDP1 somatic frameshift mutations in colorectal cancer, n = 98 and two BDP1 variants associated with poor clinical outcomes in neuroblastoma.36 This evidence concerns the gene BDP1 and neuroblastoma.